November 6-7, 2012 | Philadelphia, PA
Can you have true open innovation in a competitive marketplace? What can you learn from current pre-competitive collaboration models and case studies to implement in the “closed” space of clinical development? Learn how the pharma industry and its innovation leaders are changing the game of asset discovery and development. Identify which tools, such as crowdsourcing and outsourcing, and frameworks (collaborations, partnerships, external research) your organization is ready to implement and listen to in-depth case studies. Presentations will focus on how to optimize external asset innovation, new IP and collaboration language to accelerate processes, and the frameworks of successful pre-competitive and competitive collaboration models. Present your work on the resource changes that are required to allow open innovation or how you have implemented practices internally to drive collaboration. Learn how to turn your organization into a multi-channel innovation machine. Meet with fellow executives from the industry and thought leaders to discuss the impact of innovation (or the lack of it) on the industry in the next 10 years.
Topics to include:
- Crowdsourcing
- Identifying external assets
- Engaging open innovation within your leadership
- In-licensing assets
- Innovation platforms
- Innovation tools
- Open vs. closed innovation
- IT tools and solutions
- Executive think-tank solution series
- Technology to facilitate open innovation
- Innovation in both "R" & "D"
- Case studies from pre-competitive collaborations
- Case studies from alliances & partnerships
- Lessons learned from industry leaders
- Next steps for trailblazing companies
- Disease-based medicine vs. drug-based medicine
- Novel paradigms for 2015 and beyond
How have you and your organization contributed to open innovation? Share your thoughts, successes and challenges by joining the presenting faculty at this executive meeting. Executives in innovation, strategy, collaboration/alliance management and business development who wish to present their knowledge and expertise to their colleagues are asked to submit an abstract. Remember to specify the conference that you are interested in and please provide your full contact information.
All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program.
If you are interested in presenting, please click here to submit a speaking proposal for review.
Deadline for submission is June 20, 2012
We welcome your comments, suggestions and speaker referrals as we shape the 2012 program.
For more details on the conference, please contact:
Kate Skaare
Conference Producer
Cambridge Healthtech Institute
T: (+1) 781-972-5406
E: kskaare@healthtech.com
For exhibit & sponsorship opportunities, please contact:
Carol Dinerstein
Director, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5471
E: dinerstein@healthtech.com